Literature DB >> 29869147

Microscopic polyangiitis necrotizing glomerulonephritis associated with pregnancy: case with a 20-year clinical course and review of the literature.

Yoichi Oshima1, Tatsuya Suwabe2, Yuji Marui2, Noriko Hayami2, Eiko Hasegawa2, Masayuki Yamanouchi2, Rikako Hiramatsu2, Keiichi Sumida2, Masahiro Kawada2, Akinari Sekine2, Hiroki Mizuno2, Masahiko Oguro2, Junichi Hoshino2, Naoki Sawa2, Yasuo Ishii2, Takeshi Fujii3, Kenichi Ohashi4, Kenmei Takaichi2,5, Yoshifumi Ubara2,5.   

Abstract

A 29-year-old woman with past medical history of hypertension was referred to our hospital for the evaluation of kidney dysfunction (serum creatinine 1.0 mg/dL), proteinuria (0.54 g/gCre), and microscopic hematuria. Renal biopsy before the first pregnancy was supportive for benign nephrosclerosis with no evidence of vasculitis. After her second pregnancy and delivery when she was 32 years old, she developed proteinuria of 3.2 g/gCre, hematuria, and elevated serum creatinine level of 2.6 mg/dL. Second renal biopsy revealed necrotizing glomerulonephritis and her serum MPO-ANCA was positive, leading to the diagnosis of MPA/renal-limited vasculitis (RLV). Interestingly, frozen preserved serum from 4 years earlier also tested positive for MPO-ANCA. Despite intensive treatment, hemodialysis was required 10 years later due to progressive deterioration of renal function. At that time, she developed pericarditis, bloody cardiac tamponade, and pulmonary alveolar hemorrhage, resulting in a diagnosis of systemic vasculitis MPA. She received living donor kidney transplantation at the age of 44 years, after which serum creatinine has been stable around 1.1 mg/dL without proteinuria or hematuria and MPO-ANCA has remained negative. The association of vasculitis with pregnancy and delivery is not well documented, especially in patients with MPA. Here, we report this MPO-ANCA positive woman developing MPA necrotizing glomerulonephritis after her second pregnancy and a 20-year clinical course.

Entities:  

Keywords:  Delivery; MPO-ANCA; Microscopic polyangiitis; Necrotizing glomerulonephritis; Pregnancy

Mesh:

Substances:

Year:  2018        PMID: 29869147      PMCID: PMC6181901          DOI: 10.1007/s13730-018-0342-1

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  28 in total

1.  Cyclosporin in Wegener's granulomatosis with renal failure.

Authors:  J C Borleffs; J C van der Zwan
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

2.  Hypersensitivity vasculitis (microscopic polyangiitis) in pregnancy with transmission to the neonate.

Authors:  M R Morton
Journal:  Br J Obstet Gynaecol       Date:  1998-08

3.  Relapsing Wegener's granulomatosis: successful treatment with cyclosporin-A.

Authors:  C Georganas; D Ioakimidis; C Iatrou; B Vidalaki; K Iliadou; P Athanassiou; T Kontomerkos
Journal:  Clin Rheumatol       Date:  1996-03       Impact factor: 2.980

4.  Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab.

Authors:  Alvise Berti; Giulio Cavalli; Corrado Campochiaro; Barbara Guglielmi; Elena Baldissera; Stefano Cappio; Maria Grazia Sabbadini; Claudio Doglioni; Lorenzo Dagna
Journal:  Semin Arthritis Rheum       Date:  2015-02-20       Impact factor: 5.532

Review 5.  Updates in ANCA-associated vasculitis.

Authors:  Christian Pagnoux
Journal:  Eur J Rheumatol       Date:  2016-01-29

6.  Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement.

Authors:  Priya J Bansal; Mary C Tobin
Journal:  Ann Allergy Asthma Immunol       Date:  2004-10       Impact factor: 6.347

7.  Pregnancy outcomes among patients with vasculitis.

Authors:  Megan E B Clowse; Rachel L Richeson; Carl Pieper; Peter A Merkel
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-08       Impact factor: 4.794

8.  Corticosteroid-free treatment of tocilizumab monotherapy for microscopic polyangiitis: a single-arm, single-center, clinical trial.

Authors:  Ryota Sakai; Tsuneo Kondo; Jun Kikuchi; Akiko Shibata; Kentaro Chino; Ayumi Okuyama; Hirofumi Takei; Koichi Amano
Journal:  Mod Rheumatol       Date:  2016-04-21       Impact factor: 3.023

9.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01

10.  Clinical and pathological analysis of the kidney in patients with hypertensive nephropathy.

Authors:  Xiang-Chuan Wang; Chun-Hui Liu; Yun-Jing Chen; Yang Wu; Lei-Shan Yang; Hong-Min Liu; Hai-Li Liao
Journal:  Exp Ther Med       Date:  2013-09-18       Impact factor: 2.447

View more
  2 in total

1.  Flare of eosinophilic granulomatosis with polyangiitis related to pregnancy: Case report and review of the literature.

Authors:  Osamu Matsuno; Seijiro Minamoto
Journal:  Respir Med Case Rep       Date:  2018-11-04

Review 2.  Pregnancy Outcomes in Systemic Vasculitides.

Authors:  Carolyn Ross; Rohan D'Souza; Christian Pagnoux
Journal:  Curr Rheumatol Rep       Date:  2020-08-26       Impact factor: 4.592

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.